Health & Wellness News
← Back to all newslettersLosing just 80 minutes of sleep a night could make you gain weight
Sleeping about an hour and 20 minutes less each night for six weeks caused participants to gain weight and spend more time inactive. Researchers found that even mild, realistic sleep loss, similar to what many adults experience, had measurable effects. They warn that if this pattern continues over months or years, the health consequences could become much more significant, including a higher risk of diabetes and heart disease.
Where you live could shape your dementia risk, massive study finds
Researchers analyzing data from more than 214,000 people found that dementia risk factors differ widely across countries, challenging the idea of a one-size-fits-all prevention strategy. At the same time, they uncovered surprisingly consistent patterns that could help shape smarter, more targeted public health efforts.
Scientists discover a hidden heart valve risk linked to gum disease
Researchers found that bacteria linked to gum disease may help drive the development of calcific aortic valve stenosis by triggering inflammation and calcium buildup in the heart valve. The early findings suggest that keeping gums healthy could play a role in reducing the risk of this serious heart condition.
Scientists discover how the brain rewires itself to truly multitask
Practice may do more than make perfect. Researchers found that extensive training physically reorganizes the brain, allowing learned tasks to bypass the prefrontal cortex and run through specialized circuits instead. By freeing the brain's "thinking" center, people became better at performing another task at the same time, challenging the long-held idea that humans only switch rapidly between tasks rather than truly multitask.
Columbia scientists discover surprising link between serotonin and heart valve disease
Scientists have uncovered evidence that serotonin, the chemical best known for regulating mood, may also speed the progression of a common heart valve disease in some people. The research suggests that patients with degenerative mitral regurgitation who take SSRI antidepressants and carry a specific genetic variant may develop severe valve damage sooner, potentially requiring surgery at a younger age.
Experimental drug reverses severe fatty liver disease by repairing the gut
An experimental drug called DT-109 reversed severe fatty liver disease in animal studies by repairing the gut and preventing harmful toxins from damaging the liver. The discovery could open the door to a new class of treatments for MASH and potentially other diseases tied to gut health.
Second pregnancy changes the brain in surprising new ways
Researchers found that every pregnancy rewires the brain in its own way, with a second pregnancy bringing a different pattern of changes than the first. The discoveries could lead to better ways to recognize and treat maternal mental health challenges, including peripartum depression.
This frog bacterium wiped out cancer tumors in mice with a single dose
A naturally occurring bacterium from amphibian intestines completely eliminated colorectal tumors in mice with a single treatment by both attacking cancer cells and activating the immune system. The findings point to a promising new type of cancer therapy that could one day work against many solid tumors.
A hidden immune backup system could supercharge mRNA cancer vaccines
Researchers found that mRNA cancer vaccines can recruit an unexpected immune cell to launch powerful tumor-fighting responses, overturning a long-held assumption about how the vaccines work. The discovery could lead to more effective cancer vaccines and help scientists tailor treatments for better patient outcomes.
A vitamin A discovery is changing what scientists know about vision
A surprising discovery is reshaping scientists' understanding of how humans develop sharp central vision before birth. Instead of blue cone cells migrating away from the retina's center, the study found they transform into red and green cones under the influence of vitamin A-related signals and thyroid hormones. The findings could improve lab-grown retinal tissue and lay the groundwork for future cell therapies to restore vision lost to age-related eye diseases.
The Ozempic and Wegovy mistake sending thousands to poison control
Poison control calls involving semaglutide (Ozempic and Wegovy) soared after the drug was approved for weight management, with researchers linking the increase to accidental dosing mistakes rather than intentional misuse. Simple education about proper weekly dosing and gradual dose increases could help prevent many of these avoidable incidents.
Harvard scientists turn a silicon chip into a DNA writing machine
Scientists have created a silicon chip that can write dozens of DNA sequences simultaneously using electricity and water-based enzymes, offering a cleaner alternative to conventional DNA manufacturing. The breakthrough could eventually support portable DNA-writing devices and even massive DNA data storage, although new chemistry will be needed to scale the technology further.
Creatine doesn't just build muscle. It may also help fight cancer
Scientists have discovered that creatine may strengthen one of the immune system's most important cancer-fighting pathways by energizing dendritic cells that activate killer T cells. The promising results could eventually help make immunotherapy more effective, but they have not yet been tested in human patients.
Can't stick to a diet? Intermittent fasting may be easier than counting calories for weight loss
Intermittent fasting helped people lose as much weight as calorie restriction, but without the same feeling of constantly controlling their food intake. Researchers say that difference could make fasting a more sustainable option for people who struggle with traditional diets.
New weight loss pill beats oral Ozempic in major trial
A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the leading oral semaglutide in a major clinical trial. The tablet could offer a more convenient alternative to injectable drugs like Ozempic and Wegovy because it doesn't require refrigeration or special timing with meals. It's also cheaper to manufacture, which could expand access globally.